Incontinentia Pigmenti
What's New
Last Posted: Apr 21, 2023
- The Impact of the IKBKG Gene on the Appearance of the Corpus Callosum Abnormalities in Incontinentia Pigmenti.
Mini? Snežana, et al. Diagnostics (Basel, Switzerland) 2023 0 (7) - Unraveling incontinentia pigmenti: A comparison of phenotype and genotype variants.
Wang Rebecca, et al. Journal of the American Academy of Dermatology 2019 0 (5) 1142-1149 - Importance of extracutaneous organ involvement in determining the clinical severity and prognosis of incontinentia pigmenti caused by mutations in the IKBKG gene.
Kim Hwa Young, et al. Experimental dermatology 2021 0 (5) 676-683 - Clinical and histologic features of incontinentia pigmenti in adults with nuclear factor-?B essential modulator gene mutations.
Hadj-Rabia Smaïl, et al. Journal of the American Academy of Dermatology 2011 0 (3) 508-15 - Clinical utility gene card: for incontinentia pigmenti.
Fusco Francesca et al. European journal of human genetics : EJHG 2019 Jul - The Incontinentia Pigmenti Genetic Biobank: study design and cohort profile to facilitate research into a rare disease worldwide.
Fusco Francesca et al. European journal of human genetics : EJHG 2019 Jun - Clinical Utility Gene Card for: incontinentia pigmenti.
- Incontinentia pigmenti
From NCATS Genetic and Rare Diseases Information Center
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: